A Case Report of Successful Treatment With Crizotinib to Overcome Resistance to Osimertinib in an EGFR Mutated Non-Small-Cell Lung Cancer Patient Harboring an Acquired MET Exon 14 Mutation.

Clin Lung Cancer

Department of Respiratory Diseases, Le Mans Hospital Center, 72000 Le Mans, France. Electronic address:

Published: March 2022

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.cllc.2021.06.002	DOI Listing

Publication Analysis

case report

report successful

successful treatment

treatment crizotinib

crizotinib overcome

overcome resistance

resistance osimertinib

osimertinib egfr

egfr mutated

mutated non-small-cell

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!